Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 21, 2022 OWNERSHIP DOCUMENT
8-K Jun 21, 2022 8-K
4 Jun 17, 2022 FORM 4 SUBMISSION
4 Jun 17, 2022 FORM 4 SUBMISSION
4 Jun 17, 2022 FORM 4 SUBMISSION
4 Jun 17, 2022 FORM 4 SUBMISSION
4 Jun 17, 2022 FORM 4 SUBMISSION
4 Jun 17, 2022 FORM 4 SUBMISSION
10-Q May 16, 2022 10-Q
8-K May 16, 2022 8-K
DEFA14A Apr 27, 2022 DEFA14A
DEF 14A Apr 27, 2022 DEF 14A
4 Apr 4, 2022 FORM 4 SUBMISSION
3 Apr 4, 2022 FORM 3 SUBMISSION
S-8 Mar 29, 2022 S-8
10-K Mar 28, 2022 10-K
8-K Mar 28, 2022 8-K
SC 13G Feb 16, 2022 SCHEDULE 13G
SC 13G Feb 15, 2022 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
SC 13G Feb 14, 2022 SC 13G
SC 13G Feb 4, 2022
SC 13G Jan 27, 2022
4 Jan 21, 2022 FORM 4 SUBMISSION
4 Jan 21, 2022 FORM 4 SUBMISSION
4 Jan 21, 2022 FORM 4 SUBMISSION
← Newer Page 12 of 15 · 365 filings Older →